Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haijun Tang

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
BMC Medicine|May 16, 2024
Single-cell and spatial transcriptomics reveal metastasis mechanism and microenvironment remodeling of lymph node in osteosarcomaYun Liu, Mingwei He, Haijun Tang, et al.
BMC Medicine|January 24, 2025
Development a glycosylated extracellular vesicle-derived miRNA Signature for early detection of esophageal squamous cell carcinomaJianlin Chen, Yue Zheng, Zhen Wang, et al.
APL Bioengineering|January 5, 2026
Formononetin suppresses osteosarcoma by targeting MYO1B and remodeling the tumor immune microenvironmentYun Liu, Liang Xiong, Wenyu Feng, et al.
APL Bioengineering|August 11, 2025
Single-cell RNA and bulk sequencing analysis reveals that formononetin inhibits GTSF1 to exert anti-osteosarcoma effectsTianyu Xie, Jiming Liang, Chengsen Lin, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
BMC Medicine|May 16, 2024
Single-cell and spatial transcriptomics reveal metastasis mechanism and microenvironment remodeling of lymph node in osteosarcomaYun Liu, Mingwei He, Haijun Tang, et al.
BMC Medicine|January 24, 2025
Development a glycosylated extracellular vesicle-derived miRNA Signature for early detection of esophageal squamous cell carcinomaJianlin Chen, Yue Zheng, Zhen Wang, et al.
APL Bioengineering|January 5, 2026
Formononetin suppresses osteosarcoma by targeting MYO1B and remodeling the tumor immune microenvironmentYun Liu, Liang Xiong, Wenyu Feng, et al.
APL Bioengineering|August 11, 2025
Single-cell RNA and bulk sequencing analysis reveals that formononetin inhibits GTSF1 to exert anti-osteosarcoma effectsTianyu Xie, Jiming Liang, Chengsen Lin, et al.
Pageof 9